Nacimiento W, Schmitt A B, Brook G A
Neurologische Klinik, Medizinische Fakultät der Rheinisch Westfälischen Technischen Hochschule, Aachen.
Nervenarzt. 1999 Aug;70(8):702-13. doi: 10.1007/s001150050499.
In recent years, a more precise neurobiological knowledge has been gained concerning the various cellular parameters which mediate successful peripheral nerve regeneration, and also those which prevent repair of damaged nerve fibre pathways following traumatic injury to the the central nervous system (CNS). On this basis, a range of experimental therapeutical approaches for promoting axonal regeneration and functional recovery after spinal cord injury have been developed in animal models. Such intervention strategies focus on the molecular inactivation of glial-associated growth-inhibitory factors and on the application of trophic molecules and cellular substrates which enhance the postlesional regenerative potential of intrinsic CNS neurons. At the present, these experimental therapies cannot be transferred to the clinical situation for the treatment of spinal cord injured patients. This overview briefly summarizes current progress in the neurobiology of spinal cord trauma, the main findings of which are discussed in the light of clinical expectations.
近年来,我们在神经生物学方面获得了更为精确的知识,涉及介导外周神经成功再生的各种细胞参数,以及那些在中枢神经系统(CNS)遭受创伤性损伤后阻碍受损神经纤维通路修复的参数。在此基础上,已经在动物模型中开发了一系列促进脊髓损伤后轴突再生和功能恢复的实验性治疗方法。此类干预策略聚焦于与胶质细胞相关的生长抑制因子的分子失活,以及应用营养分子和细胞基质,以增强中枢神经系统固有神经元损伤后的再生潜力。目前,这些实验性疗法尚无法应用于脊髓损伤患者的临床治疗。本综述简要总结了脊髓创伤神经生物学的当前进展,并根据临床期望对其主要发现进行了讨论。